Presentation is loading. Please wait.

Presentation is loading. Please wait.

Percentages of peripheral blood CD4 and CD8 T cells expressing the activation markers HLA-DR and CD25 in the atopic asthmatics (AA), atopic controls (AC),

Published byVirgil Hicks Modified over 5 years ago

Similar presentations

Presentation on theme: "Percentages of peripheral blood CD4 and CD8 T cells expressing the activation markers HLA-DR and CD25 in the atopic asthmatics (AA), atopic controls (AC),"— Presentation transcript:

1 Percentages of peripheral blood CD4 and CD8 T cells expressing the activation markers HLA-DR and CD25 in the atopic asthmatics (AA), atopic controls (AC), nonatopic asthmatics (NAA), and nonatopic controls (NAC) at the commencement of the study. Percentages of peripheral blood CD4 and CD8 T cells expressing the activation markers HLA-DR and CD25 in the atopic asthmatics (AA), atopic controls (AC), nonatopic asthmatics (NAA), and nonatopic controls (NAC) at the commencement of the study. P values by 2-sample t test. Vasso Gemou-Engesæth et al. Pediatrics 2002;109:e24 ©2002 by American Academy of Pediatrics

Download ppt "Percentages of peripheral blood CD4 and CD8 T cells expressing the activation markers HLA-DR and CD25 in the atopic asthmatics (AA), atopic controls (AC),"

Similar presentations

SSC -A SLAN CD16 CD14 CD3-CD19-CD56 CD123 HLA-DR CD33

SSC -A SLAN CD16 CD14 CD3-CD19-CD56 CD123 HLA-DR CD33
Side Scatter Forward Scatter Lineage CD1c CD141 CD303 lineage negative

Side Scatter Forward Scatter Lineage CD1c CD141 CD303 lineage negative
Overview of next-generation sequencing, neoantigen prediction, and functional T-cell analyses. Overview of next-generation sequencing, neoantigen prediction,

Overview of next-generation sequencing, neoantigen prediction, and functional T-cell analyses. Overview of next-generation sequencing, neoantigen prediction,
by Venetia Bigley, Laura E. Spence, and Matthew Collin

by Venetia Bigley, Laura E. Spence, and Matthew Collin
Nighttime parent experience.

Nighttime parent experience.
Diagnosis, risk classification, and recommended management of a BRUE

Diagnosis, risk classification, and recommended management of a BRUE
Percentage of nursing assessments with NEWS documented for patients 21 years and older from March to October 2015. Percentage of nursing assessments with.

Percentage of nursing assessments with NEWS documented for patients 21 years and older from March to October Percentage of nursing assessments with.
Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Complex interactions between B cells and dendritic cells

Complex interactions between B cells and dendritic cells
Figure 3 Decreased AHI1 in human CD4+ T cells is associated with decreased proliferation and increased IFNγ production Decreased AHI1 in human CD4+ T cells.

Figure 3 Decreased AHI1 in human CD4+ T cells is associated with decreased proliferation and increased IFNγ production Decreased AHI1 in human CD4+ T cells.
Figure 1 Effect of DMF therapy on T cell subsets

Figure 1 Effect of DMF therapy on T cell subsets
Figure 5 Increased frequency of parenchymal CD138- and LMP-1–positive cells in MS Increased frequency of parenchymal CD138- and LMP-1–positive cells in.

Figure 5 Increased frequency of parenchymal CD138- and LMP-1–positive cells in MS Increased frequency of parenchymal CD138- and LMP-1–positive cells in.
Figure 2 Alemtuzumab-induced changes in the dendritic cell compartment

Figure 2 Alemtuzumab-induced changes in the dendritic cell compartment
Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response 

Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response 
Figure 1 Peripheral blood leukocyte subset counts during dimethyl fumarate treatmentComplete blood cell counts were obtained at baseline (n = 34) and at.

Figure 1 Peripheral blood leukocyte subset counts during dimethyl fumarate treatmentComplete blood cell counts were obtained at baseline (n = 34) and at.
Prathap Pillai, MD, Cailong Fang, PhD, Yih-Chih Chan, PhD, Mohamed H

Prathap Pillai, MD, Cailong Fang, PhD, Yih-Chih Chan, PhD, Mohamed H
d a c b CD8 CD3 CD4 CD62L HLA-DR CD57 10% 85% 11% 76% 19% 60% 36% 66%

d a c b CD8 CD3 CD4 CD62L HLA-DR CD57 10% 85% 11% 76% 19% 60% 36% 66%
Figure 2 CD4+ and CD8+ T cells accumulate in the CSF in GABAB receptor antibody–associated LE CD4+ and CD8+ T cells accumulate in the CSF in GABAB receptor.

Figure 2 CD4+ and CD8+ T cells accumulate in the CSF in GABAB receptor antibody–associated LE CD4+ and CD8+ T cells accumulate in the CSF in GABAB receptor.
Figure 1 Schematic overview of flow cytometry Schematic overview on the analysis of peripheral immune cells by flow cytometry. Schematic overview of flow.

Figure 1 Schematic overview of flow cytometry Schematic overview on the analysis of peripheral immune cells by flow cytometry. Schematic overview of flow.
Figure 1 Evolution of blood cell counts during 18-month treatment and follow-up (A) Mean white blood cell count, (B) mean lymphocyte count, (C) mean eosinophil.

Figure 1 Evolution of blood cell counts during 18-month treatment and follow-up (A) Mean white blood cell count, (B) mean lymphocyte count, (C) mean eosinophil.

Similar presentations

Ads by Google